Amneal Pharmaceuticals Stock Reaches 52-Week High on Q2 Surpasses

Amneal Pharmaceuticals Inc. (AMRX) reached a 52-week high of $19.32 per share on Thursday, reflecting robust second-quarter performance and positive analyst revisions. The company’s market capitalization stands at $6.62 billion, with total returns over the past year climbing 88.05% and adjusted earnings per share (EPS) exceeding forecasts by 30%. Revenue for Q2 surpassed expectations by 5.1%, reaching $796.2 million against an anticipated $758.24 million, while adjusted EPS came in at $0.30, surpassing the $0.23 estimate.